Dr. P. A. Jiwani

• Dr. P. A. Jiwani is an experienced Interventional Cardiologist, practicing for the past 23 years. 


• In 2008, he was the President of the AP Cardiology Society of India.


• He completed MBBS in 1977 and MD in Internal Medicine in 1981 from Government Medical College, Nagpur. 


• He also did Diploma in Cardiology from the University of London Royal Postgraduate Medical School Hamar Smith Hospital, London, in 1989, and DNB in Cardiology from Nizam’s Institute of Medical Sciences Hyderabad in 1992.


• He did special training in Interventional Cardiology from Nizam’s Institute of Medical Sciences Hyderabad and Charles De Nicole Hospital University of Ruien, France.


• He is an active member of the Cardiology Society of India, European Society of Cardiology, Academy of Medical Sciences, India, and Indian Medical Association.


• He has published many papers and articles.
  
   

President, AP Cardiology Society of India - 2008
Independent Executive Director, Vijayasree Organics Ltd, Hyderabad. - 2009
Member , Advisory Board, Krishna Institute of Medical Sciences, Secunderabad. - 2016... Read Less

• MICHELANGELO OASIS – 6 (STEMI) STUDY) – an international randomized study evaluating the efficacy and safety of Fondaparinux sodium vs. control therapy in broad range of patients with ST segment elevation Acute MI.


• PLATO STUDY - A Randomized, Double blind, parallel group, phase 3, Efficacy and safety study of AZD6 140 Compared with Clopidogrel for prevention of vascular events in patients with Non –ST or ST elevation Acute Coronary Syndrome (ACS)


• OASIS -7 (CURRENT) STUDY) – Randomized, Multinational, double blind study, comparing a high loading dose regimen of Clopidogrel versus standard dose in patient with Unstable Angina or myocardial infarction managed with an early invasive strategy – Oasis -7 Study.


• XIENCE V Registry –Xience Everolimus Eluting Coronary Stent System (EECSS) India Post Marketing Registry.


• LIFENOX STUDY – International multicenter, randomized, double blind study to compare the overall mortality in acutely ill medical patients treated with enoxaparin versus placebo in addition to Graduated Elastic Stockings. MICHELANGELO OASIS – 6 (STEMI) STUDY) – an international randomized study evaluating the efficacy and safety of Fondaparinux sodium vs. control therapy in broad range of patients with ST segment elevation Acute MI.


• PLATO STUDY - A Randomized, Double blind, parallel group, phase 3, Efficacy and safety study of AZD6 140 Compared with Clopidogrel for prevention of vascular events in patients with Non –ST or ST elevation Acute Coronary Syndrome (ACS)


• OASIS -7 (CURRENT) STUDY) – Randomized, Multinational, double blind study, comparing a high loading dose regimen of Clopidogrel versus standard dose in patient with Unstable Angina or myocardial infarction managed with an early invasive strategy – Oasis -7 Study.